MSB-2179

N/A

Report date: 2025/08/27 17:31:45

Base Information

Drug NameMSB-2179
Drug Alias NameMSB-2179
ClassificationBiologics > Live Biotherapeutic
Mechanisms of ActionBacteria replacementsMicrobiome modulators
TargetsNot applicable
Therapy Area/IndicationsIchthyosiform Erythroderma, Congenital
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of California
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of California
Inactive CompaniesN/A
Active IndicationsIchthyosiform Erythroderma, Congenital
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A